UPDATE: Oppenheimer Upgrades Inspire Medical Systems (INSP) to Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Inspire Medical Systems (INSP) PT Raised to $140 at Wells Fargo
November 3, 2020 5:43 AM ESTWells Fargo raised its price target on Inspire Medical Systems (NYSE: INSP) to $140.00 (from $135.00) while maintaining a Overweight rating.... More
After-Hours Stock Movers 11/02: (IEA) (ANET) (CRUS) Higher; (SEDG) (PYPL) (NPTN) Lower (more...)
November 2, 2020 5:44 PM ESTToday's After-Hours Stock Movers:
Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) 19.4% HIGHER; announced a joint venture with F.H. Paschen for the West Lake Corridor rail expansion awarded by the Northern Indiana Commuter Transportation District (NICTD) and valued at over $550 million. The contract was secured by Ragnar Benson, a subsidiary of IEA that provides heavy- and light-rail construction, and F.H. Paschen, a general contractor and construction manager with over 110 years of experience in the construction industry.
Inspire Medical Systems (INSP) Tops Q3 EPS by 33c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus
November 2, 2020 5:01 PM ESTInspire Medical Systems (NYSE: INSP) reported Q3 EPS of ($0.39), $0.33 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $22.75 million.
Recent Business Highlights
Generated revenue of $35.8 million in the third quarter of 2020, a 72% increase over the same quarter last yearReported gross margin of 85.5% in the third quarter of 2020, an increase over the 83.4% reported in the same quarter last yearActivated 42 new centers in the third quarter of 2020, bringing the total to 370 U.S. medical centers implanting Inspire therapyCreated... More